GeoVax Labs(us:GOVX)

    2.21

    -3.49%

    Updated on 2024-12-23

    Open:2.33
    Close:2.21
    High:2.33
    Low:2.13
    Pre Close:2.29
    Volume:673604.00
    Amount:1.47M
    Turnover:7.14%
    Shares:9.44M
    MarketCap:20.83M

    About GeoVax Labs Company

    GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

    Company Name: GeoVax Labs
    Company Address: 1900 Lake Park Drive,Suite 380
    Employees: 17
    Fiscar Year: 12-31
    IPO Date: 2020-09-25
    CIK: 832489

    View all SEC Filings

    About

    GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
    Address:1900 Lake Park Drive,Suite 380

    Market Movers